About

Mar 16-17, 2023    London, UK

4th International Conference on

Rare Diseases and Orphan Drugs

Longdom conferences Hosting 200+ leading international conferences and virtual events annually. It is instrumental in bringing together experts and learners from all over the globe for mutual growth and effective research-oriented discussions. As per the present market demand and growth in the field of Rare Diseases and Orphan Drugs research, Longdom meetings  is hosting its "4th International Conference on Rare Diseases & Orphan Drugs" This is scheduled for March 16-17, 2023 in London, UK. Rare Diseases 2023 focus on health and infectious diseases including basic, clinical and prevention research. It brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments and best research methods in the on going battle against Orphan Drug and related rare diseases. The field of Rare Diseases is growing rapidly, and its development is making tremendous impacts in Medical and Healthcare, Rare Diseases and Orphan Drugs will generally accompany issues like major Sexual Transmitted Diseases their transmission and eradication problems. This leads to improvement in Current pharmaceutical design from which new experimental drugs are developed.


Conference Scientific Sessions:

Track 1: Challenges of Living with a Rare Diseases

Focusing within the coordination between medical, social and support services in order to handle the challenges that people living with a rare disease and their families around the world confront each day. Even if rare disease patients and their families face several challenges, enormous progress is being made daily. Most rare diseases don’t have any cure, thus living with a rare infection is an on-going learning experience for patients and families. Day-by-day, hand-in-hand, together we present a united voice to advocate for the treatments, care, resources and services we all need. Managing these care-related tasks alongside their usual daily activities such as work, school and leisure time can be challenging.

Related Conferences: Rare Disease Conference | Orphan Drug Event | Rare Disease Meetings | Disease Conference | Disease Congress | Infectious Disease Conference | Infectious Disease EventOrphan Drug Conference

Track 2: Rare Genetic Diseases

There are various reasons for rare infections. The greater part is thought to be hereditary, caused by changes in qualities or chromosomes. In a couple of cases, hereditary changes are the reason infection passes starting with one generation then to the other. In different cases, they happen arbitrarily in an individual who is the essential in a family to be analyzed. These ailments have horrible names. Now and again they are even anonymous. Because of the absence of interest in research, we are still new with the causes or segments of the vast majority of the uncommon hereditary sicknesses logically known to exist. Chromosome issue are of two sorts numerical and basic. Now and again chromosome variations from the norm occur during the advancement of an egg or sperm cell, and different occasions they occur after origination. Chromosome issue might be suspected in individuals who have formative deferrals, scholarly handicaps or potentially physical irregularities.

Related Conferences: Rare Disease Conference | Orphan Drug Event | Rare Disease Meetings | Disease Conference | Disease Congress | Infectious Disease Conference | Infectious Disease EventOrphan Drug Conference

Track 3: Rare Pediatric Diseases

Children affecting with rare diseases are Rare Paediatric diseases, there are different reasons for paediatric infections some of the rare paediatric diseases are, Congenital Heart Defects, Eisenmenger Syndrome, Kawasaki Diseaseand Achondrogenesis. Rare paediatric diseases is a serious or life-threatening disease, affect people aged from birth to 18 years, including age groups often called neonates, infants, children, and adolescents. is one of the cases of paediatric rare infection. Paediatric rare diseases have received better consideration in recent years due to greater public awareness, significantly improved understanding and treatment of the relatively more common disorders, elimination of nutritional deficiencies and the advancement of laws related to the treatment of rare diseases.

Related Conferences: Rare Disease Conference | Orphan Drug Event | Rare Disease Meetings | Disease Conference | Disease Congress | Infectious Disease Conference | Infectious Disease EventOrphan Drug Conference

Track 4: Rare Skin Diseases

Most of the diseases influences the skin arise within the layers of the skin, such defects are also important aspects in the diagnosis of a variety of internal diseases. The skin has an innate district explicit anatomical assorted variety which will significantly alter the presence of a rash. This is apparent when skin transplanted from one area of the body to another retains the morphological characteristics of the donor area. The classification of hereditary skin disorders generally has been based upon gross morphological, histological and electron microscopic findings, because a skin disease may not always have a characteristic presentation, the specific diagnosis sometimes has been in doubt.

Related Conferences: Rare Disease Conference | Orphan Drug Event | Rare Disease Meetings | Disease Conference | Disease Congress | Infectious Disease Conference | Infectious Disease EventOrphan Drug Conference

Track 5: Vaccines and Vaccination

Vaccines are the biological preparations that are able to improve immunity from a disease and can be administered through needle injections. A vaccine contains an agent which resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe or its toxins. The agent stimulates the body’s immune system to identify it as foreign, destroy it, and remember it, so that the immune system can more easily identify and destroy any of these microorganisms that it encounters later. The body’s immune system responds to vaccines as if they contain an actual pathogen, even though the vaccine itself is not capable of causing disease. Vaccinated individuals produce antibodies which neutralize the disease caused by virus or bacteria. They are less possible to become infected and transmit those germs to others.

Related Conferences: Rare Disease Conference | Orphan Drug Event | Rare Disease Meetings | Disease Conference | Disease Congress | Infectious Disease Conference | Infectious Disease EventOrphan Drug Conference

Track 6: Rare Diseases

A rare disease, also known to as an orphan disease, is any disease that influences a small percentage of the population. Most rare diseases are genetic, and are present throughout an individual's entire life, even if symptoms do not immediately appear. Rare diseases are portrayed by a wide diversity of symptoms and signs that fluctuate not only from disease to disease but also from patient to patient suffering from the same disease. Relatively common signs can hide underlying rare diseases, leading to misdiagnosis. Many rare diseases appear early in life. The exact source for many rare diseases remains unknown. But Environmental factors, viral contaminations, genetic mutations, diet, smoking, or exposure to chemicals, also can play a role in rare diseases.

Related Conferences: Rare Disease Conference | Orphan Drug Event | Rare Disease Meetings | Disease Conference | Disease Congress | Infectious Disease Conference | Infectious Disease EventOrphan Drug Conference

Track 7: Future of Rare Diseases Research

It is still a reality for rare disease patients to spend years in the health care system before an accurate diagnosis is made. Next-generation sequencing and improved data sharing have give rise in faster discovery of gene disease and thus diagnostics. However the rate of gene disease discovery is now reducing maybe as a consequence of the likely complex origin of the remaining unsolved disease. To face this challenge, new methods in particular addressing non coding region of the genome will need to be developed. In addition, even if the rate of rare disease therapeutic development and approval has been increasing, some percentage of rare diseases still lack an approved treatment. Due to variations of rare infections, research has to be worldwide to ensure that specialists, researchers and clinicians are connected, that clinical trials are multinational and that patients can advantage from the pooling of resources over borders.

Related Conferences: Rare Disease Conference | Orphan Drug Event | Rare Disease Meetings | Disease Conference | Disease Congress | Infectious Disease Conference | Infectious Disease EventOrphan Drug Conference

Track 8: Deadly viral diseases

Deadly viral diseases are caused due to the viruses which are tiny germs that invade into the living organisms and normal cells, by using those cells they multiply and produce viruses like themselves. They can cause damage, make changes in the cell can make us sick or can kill us. Viruses can attack different cells in our body, few examples of some deadly viral diseases are Ebola, H5N1bird Flue, Crimean-Congo Hemorrhagic Fever, and Spanish Flue, Rabies, HIV, West Nile Virus etc. There are some antiviral medicines to treat viral infection, Vaccines can also prevent us from a viral infection.

Related Conferences: Rare Disease Conference | Orphan Drug Event | Rare Disease Meetings | Disease Conference | Disease Congress | Infectious Disease Conference | Infectious Disease EventOrphan Drug Conference

Track 9: Rare Diseases of Lymphatic System

These diseases occur very rarely, consisting of fluid-filled channels they are non-malignant masses or spaces thought to be caused by the abnormal development of the lymphatic system. These formations are usually detectable at birth or after two years of age. Lymphatic malformations can affect any part of the body (except the brain), but they most commonly affect the head and neck. When recognized at birth that is congenital, lymphatic malformations tend to be soft, spongy, non-tender masses. The most common symptoms and lymphatic malformations severity differs depending upon the size and specific location of the malformation. Some lymphatic malformations can be massive or huge Lymphatic malformations can potentially cause functional impairment of nearby structures or organs and disfigurement of affected areas Irrespective of size.

Related Conferences: Rare Disease Conference | Orphan Drug Event | Rare Disease Meetings | Disease Conference | Disease Congress | Infectious Disease Conference | Infectious Disease EventOrphan Drug Conference

Track 10: Different Types of Rare Diseases

A rare disease is defined as a condition that affects less than 200,000 people. This explanation was formed by Congress in the Orphan Drug Act of 1983. There may be as many as 7,000 rare diseases. Only a few categories of rare diseases are tracked when a person is diagnosed. These include certain infectious diseases, birth defects, and cancers. It also comprises the diseases on state newborn screening tests. Because most rare diseases are not trailed, it is hard to determine the exact number of rare diseases. Most rare diseases are genetic, and thus are present throughout the person's intact life, even if symptoms do not immediately appear.

Related Conferences: Rare Disease Conference | Orphan Drug Event | Rare Disease Meetings | Disease Conference | Disease Congress | Infectious Disease Conference | Infectious Disease EventOrphan Drug Conference

 

Market report of Rare Disease

The uncommon sickness therapy market covers an itemized division wherein the hereditary illnesses section is ready to develop at a moderate speed and stay a predominant portion by remedial region. Very nearly 80% infections are of hereditary beginning. The hereditary section is ready to mirror a huge US$ 56 Bn market valuation before the finish of 2025, according to the market figures assembled in this exploration report. 

Following the hereditary sicknesses section, the oncology portion is relied upon to be the sprinter up concerning piece of the pie investigation with a relatively low development rate than the hereditary illnesses fragment. The metabolic sicknesses section is relied upon to show the most elevated development rate to mirror a CAGR of 14.2% during the estimate time of 2017 to 2025, trailed by the neurological infections fragment at 11.3% CAGR.

 

Orphan Drugs - Commercializing Rare Disease Drugs | Kx Advisors

Orphan Drugs - Commercializing Rare Disease Drugs | Kx Advisors

Past Conferences Report

Fungal Infection 2022

We gratefully thank all our wonderful  speakers and delegates for making the Fungal Infection 2022 webinar successful.

Webinar on Fungal Infection and Treatment, hosted by the Longdom Conference was held on December 27, 2022, virtually based on the theme “Repercussion of Fungal  Infections in a globalized world"

The webinar was initiated with the honourable presence of the below speakers. The list includes:

  1. Ritu Singhal, National Institute of Tuberculosis and Respiratory Diseases, India
  2. Malini R Capoor Vardhman Mahavir Medical College & Safdarjung Hospital, India
  3. Josh Smith, CEO & Chief Scientist, Premium CBD Labs LLC, USA
  4. William C Nierman, J. Craig Venter Institute, USA
  5. Ashwin Singh Chouhan, Jai Narain Vyas University, India

Fungal Diseases 2022

We gratefully thank all our wonderful  speakers and delegates for making the Fungal Diseases 2022 webinar successful.

Webinar on Fungal Diseases and Treatment, hosted by the Longdom Conference was held on April 27, 2022, virtually based on the theme “Advancements of Fungal  Diseases in a globalized world"

The webinar was initiated with the honourable presence of the below speakers. The list includes:

  1. Bassmalla Hasan, Tanta university faculty of science,  Egypt
  2. Mohamed Soud,  Zagazig University, Egypt
  3. Mohammad Soleimani, Tehran University of Medical Sciences, Iran
  4. Shanu Hoda, Amity University, India
  5. Malik Wajid H. Chan, University of Karachi, Pakistan

Infections 2022

We gratefully thank all our wonderful  speakers and delegates for making the Infections 2022 webinar successful.

Webinar on Fungal Infection and Treatment, hosted by the Longdom Conference was held on March 27, 2022, virtually based on the theme “Current Updates on Fungal  Infections"

The webinar was initiated with the honorable presence of the below speakers. The list includes:

  1. Mengyao Niu, University of Wisconsin-Madison, United States
  2. Alexandre Gomes Rodrigues, Butantan Institute, Brazil
  3. Mohammad Soleimani, Tehran University of Medical Sciences, Tehran
  4. Amira Abou-Elnour, Zagazig University, Egypt
  5. Heba Hassan Mahboub,  Zagazig University, Egypt

With the grand success of the all the above Conferences, Longdom Conferences is proud to announce the "4th International Conference on Rare Diseases and Orphan Drugs” to be held March 16-17, 2023 at London, UK.

For more details visit: https://www.longdom.com/rarediseases

  [email protected]
  [email protected]
  [email protected]
Speakers Interview